Uptake of gallium-67 by the hepatocytes during liver regeneration in carbon tetrachloride-treated mice

Biological and Pharmaceutical Bulletin

Volumn 27, Issue 12, 2004, Pages 1913-1915

  Abe, Shinya ^a   Suyama, Satoko ^a   Shishido, Hitomi ^a   Sato, Masayoshi ^a   Ohtake, Yosuke ^a   Sato, Naoko ^a   Ohkubo, Yasuhito ^a  

^a TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Bromodeoxyuridine (BrdU); Carbon tetrachloride (CCl4); Gallium 67 (67Ga); Hepatocyte; Lipid peroxidation; Liver tissue

Indexed keywords

BROXURIDINE; CARBON TETRACHLORIDE; GALLIUM 67; GALLIUM;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL TRANSPORT; CONTROLLED STUDY; DRUG UPTAKE; LIPID PEROXIDATION; LIVER CELL; LIVER DISEASE; LIVER REGENERATION; MALE; MOUSE; NONHUMAN; ANIMAL; COMPARATIVE STUDY; DRUG EFFECT; METABOLISM; PHYSIOLOGY;

ANIMALS; CARBON TETRACHLORIDE; GALLIUM RADIOISOTOPES; HEPATOCYTES; LIVER REGENERATION; MALE; MICE;

EID: 21644448738     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.27.1913     Document Type: Article

References (23)

1. Bekerman C., Hoffer P. B., Bitran J. D., Semin. Nucl. Med., 14, 296-323 (1984).
2. Halpern S. H. P., "Gallium-67 Citrate Imaging in Neoplastic and Inflammatory Disease," Raven Press, New York, 1980.
3. Hoffer P., J. Nucl. Med., 21, 484-488 (1980).
4. Lin W. Y., Lan J. L., Wang S. J., J. Nucl. Med., 39, 2137-2141 (1998).
5. Edwards C. L., Hayes R. L., J. Nucl. Med., 10, 103-105 (1969).
6. Ito Y. O. S., Sato K., Takahashi K., Sato T., Kanno I., Radiology, 100, 357-362 (1971).
7. Lavender J. P., Lowe J., Barker J. R., Burn J. I., Chaudhri M. A., Br. J. Radiol., 44, 361-366 (1971).
8. Shiomi S., Kuroki T., Yokogawa T., Takeda T., Nishiguchi S., Nakajima S., Tanaka T., Okamura T., Ochi H., J. Nucl. Med., 38, 216-219 (1997).
9. Abe S., Hasegawa S., Nirasawa M., Sato N., Ohkubo Y., Hepatol. Res., 25, 306-311 (2003).
10. Castillo T., Koop D. R., Kamimura S., Triadafilopoulos G., Tsukamoto H., Hepatology, 16, 992-996 (1992).
11. Mico B. A., Pohl L. R., Arch. Biochem. Biophys., 225, 596-609 (1983).
12. Link B., Durk H., Thiel D., Frank H., Biochem. J., 223, 577-586 (1984).
13. Tribble D. L., Aw T. Y., Jones D. P., Hepatology, 7, 377-386 (1987).
14. Haouzi D., Lekehal M., Moreau A., Moulis C., Feldmann G., Robin M. A., Letteron P., Fau D., Pessayre D., Hepatology, 32, 303-311 (2000).
15. Jaeschke H., Smith C. W., Clemens M. G., Ganey P. E., Roth R. A., Toxicol. Appl. Pharmacol., 139, 213-226 (1996).
16. Nicotera P., Bellomo G., Orrenius S., Annu. Rev. Pharmacol. Toxicol., 32, 449-470 (1992).
17. Reitman S., Frankel S., Am. J. Clin. Pathol., 28, 56-63 (1957).
18. Abe S., Hasegawa S., Nirasawa M., Sasaki M., Ohkubo Y., Biol. Pharm. Bull., 24, 1343-1346 (2001).
19. Buege J. A., Aust S. D., Methods Enzymol, 52, 302-310 (1978).
20. Abe S., Shimizu Y., Ohtsuki J., Ohkubo Y., Biol. Pharm. Bull., 25, 1209-1211 (2002).
21. Szende B., Lapis K., Kovalszky I., Timar F., In Vivo, 6, 355-361 (1992).
22. Kojima S., Hama Y., Sasaki T., Kubodera A., Eur. J. Nucl. Med., 8, 52-59 (1983).
23. Suzuki S., Nakamura N., Koizumi T., Biochim. Biophys. Acta, 428, 166-181 (1976).